Contact spotting of protein microarrays coupled with spike-in of normalizer protein permits time-resolved analysis of ERBB receptor signaling

被引:11
作者
Loebke, Christian [1 ]
Laible, Mark [1 ]
Rappl, Claudia [1 ]
Ruschhaupt, Markus [1 ]
Sahin, Oezguer [1 ]
Arlt, Dorit [1 ]
Wiemann, Stefan [1 ]
Poustka, Annemarie [1 ]
Sueltmann, Holger [1 ]
Korf, Ulrike [1 ]
机构
[1] German Canc Res Ctr, Div Mol Genome Anal, D-69120 Heidelberg, Germany
关键词
EGFR; gefitinib; HER2/neu; herceptin; reverse phase protein array;
D O I
10.1002/pmic.200700733
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Protein microarrays allow highly accurate comparison and quantification of numerous biological samples in parallel while requiring only little material. This qualifies protein arrays for systems biology and clinical research where only limited sample material is available, but a precise read-out is required. With the introduction of signal normalization steps to monitor the drop size of manually contact-spotted RP protein arrays, the usefulness of normalizer proteins to ensure a high-throughput but inexpensive protein analysis was demonstrated. This approach was applied for the analysis of signaling through ERBB receptor activated kinases in the breast cancer cell line MCF-7. Activation of ERK1/2 and AKT by ERBB1 (EGFR), ERRB2 (HER2/neu), and ERBB3-4 was monitored in a time-resolved manner. Analysis of pathway activation by stimulation with epidermal growth factor and heregulin, or inhibition by blocking with gefitinib or herceptin allowed a characterization of the distinct signaling properties of the different ERBB receptor subtypes.
引用
收藏
页码:1586 / 1594
页数:9
相关论文
共 27 条
[1]  
CALVERT VS, 2004, CLIN PROTEOM, V1, P81
[2]  
CHARBONEAU L, 2002, GENOMIC PROTEOMIC, V3, P305
[3]  
Delehanty James B, 2004, Methods Mol Biol, V264, P135
[4]   Heregulin-induced activation of HER2 and HER3 increases androgen receptor transactivation and CWR-R1 human recurrent prostate cancer cell growth [J].
Gregory, CW ;
Whang, YE ;
McCall, W ;
Fei, XY ;
Liu, YB ;
Ponguta, LA ;
French, FS ;
Wilson, EM ;
Earp, HS .
CLINICAL CANCER RESEARCH, 2005, 11 (05) :1704-1712
[5]   INSECT CELL-EXPRESSED P180(ERBB3) POSSESSES AN IMPAIRED TYROSINE KINASE-ACTIVITY [J].
GUY, PM ;
PLATKO, JV ;
CANTLEY, LC ;
CERIONE, RA ;
CARRAWAY, KL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (17) :8132-8136
[6]  
HALL D, 2006, DRUGPLUS INT, V11
[7]   Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa®, ZD1839) in chemotherapy-resistant non-small cell lung cancer [J].
Han, SW ;
Hwang, PG ;
Chung, DH ;
Kim, DW ;
Im, SA ;
Kim, YT ;
Kim, TY ;
Heo, DS ;
Bang, YJ ;
Kim, NK .
INTERNATIONAL JOURNAL OF CANCER, 2005, 113 (01) :109-115
[8]   The ErbB receptors and their role in cancer progression [J].
Holbro, T ;
Civenni, G ;
Hynes, NE .
EXPERIMENTAL CELL RESEARCH, 2003, 284 (01) :99-110
[9]   Large-scale protein expression for proteome research [J].
Korf, U ;
Kohl, T ;
van der Zandt, H ;
Zahn, R ;
Schleeger, S ;
Ueberle, B ;
Wandschneider, S ;
Bechtel, S ;
Schnölzer, M ;
Ottleben, H ;
Wiemann, S ;
Poustka, A .
PROTEOMICS, 2005, 5 (14) :3571-3580
[10]   Infrared-based protein detection arrays for quantitative proteomics [J].
Loebke, Christian ;
Sueltmann, Holger ;
Schmidt, Christian ;
Henjes, Frauke ;
Wiemann, Stefan ;
Poustka, Annemarie ;
Korf, Ulrike .
PROTEOMICS, 2007, 7 (04) :558-564